The following companies are expected to report earnings after hours on 03/08/2018. Visit our Earnings Calendar for a full list of expected earnings releases.
The Cooper Companies, Inc. ( COO ) is reporting for the quarter ending January 31, 2018. The medical/dental supplies company's consensus earnings per share forecast from the 10 analysts that follow the stock is $2.52. This value represents a 30.57% increase compared to the same quarter last year. In the past year COO has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 0.38%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for COO is 21.23 vs. an industry ratio of 18.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Marvell Technology Group Ltd. ( MRVL ) is reporting for the quarter ending January 31, 2018. The telecommunications equipment company's consensus earnings per share forecast from the 11 analysts that follow the stock is $0.27. This value represents a 50.00% increase compared to the same quarter last year. In the past year MRVL has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 7.14%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for MRVL is 23.45 vs. an industry ratio of 20.10, implying that they will have a higher earnings growth than their competitors in the same industry.
ZTO Express (Cayman) Inc. ( ZTO ) is reporting for the quarter ending December 31, 2017. The transportation services company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.28. This value represents a 86.67% increase compared to the same quarter last year. ZTO missed the consensus earnings per share in the 4th calendar quarter of 2016 by -86.36%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for ZTO is 23.60 vs. an industry ratio of 15.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Finisar Corporation ( FNSR ) is reporting for the quarter ending January 31, 2018. The fiber optics company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.13. This value represents a 72.34% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2018 Price to Earnings ratio for FNSR is 31.48 vs. an industry ratio of 25.10, implying that they will have a higher earnings growth than their competitors in the same industry.
United Natural Foods, Inc. ( UNFI ) is reporting for the quarter ending January 31, 2018. The food company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.53. This value represents a 6.00% increase compared to the same quarter last year. In the past year UNFI has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2018 Price to Earnings ratio for UNFI is 15.71 vs. an industry ratio of -39.70, implying that they will have a higher earnings growth than their competitors in the same industry.
Verifone Systems, Inc. ( PAY ) is reporting for the quarter ending January 31, 2018. The financial transactions company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.16. This value represents a 33.33% increase compared to the same quarter last year. PAY missed the consensus earnings per share in the 2nd calendar quarter of 2017 by -13.04%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for PAY is 14.98 vs. an industry ratio of 20.60.
MyoKardia, Inc. ( MYOK ) is reporting for the quarter ending December 31, 2017. The biomedical (gene) company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.40. This value represents a 190.91% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for MYOK is -33.92 vs. an industry ratio of -8.00.
TerraForm Power, Inc. ( TERP ) is reporting for the quarter ending December 31, 2017. The electric power utilities company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.48. This value represents a 48.94% increase compared to the same quarter last year. In the past year TERP and beat the expectations the other two quarters. Zacks Investment Research reports that the 2017 Price to Earnings ratio for TERP is -9.52 vs. an industry ratio of 16.00.
Marcus & Millichap, Inc. ( MMI ) is reporting for the quarter ending December 31, 2017. The real estate development company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.42. This value represents a 4.55% decrease compared to the same quarter last year. In the past year MMI has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2017 Price to Earnings ratio for MMI is 21.72 vs. an industry ratio of 35.70.
Audentes Therapeutics, Inc. ( BOLD ) is reporting for the quarter ending December 31, 2017. The biomedical (gene) company's consensus earnings per share forecast from the 8 analysts that follow the stock is $-0.92. This value represents a 1.10% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for BOLD is -9.42 vs. an industry ratio of -8.00.
Flexion Therapeutics, Inc. ( FLXN ) is reporting for the quarter ending December 31, 2017. The drug company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-1.12. This value represents a 43.59% decrease compared to the same quarter last year. The "days to cover" for this stock exceeds 15 days. Zacks Investment Research reports that the 2017 Price to Earnings ratio for FLXN is -7.14 vs. an industry ratio of -7.50, implying that they will have a higher earnings growth than their competitors in the same industry.
KMG Chemicals, Inc. ( KMG ) is reporting for the quarter ending January 31, 2018. The chemical company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.72. This value represents a 26.32% increase compared to the same quarter last year. In the past year KMG has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 31.75%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for KMG is 19.53 vs. an industry ratio of 21.50.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.